Wird geladen...
Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas
Lymphomas constitute the second most common indication for high dose therapy (HDT) followed by autologous hematopoietic cell transplantation (auto-HCT). The intent of administering HDT in these heterogeneous disorders varies from cure (e.g., in relapsed aggressive lymphomas) to disease control (e.g....
Gespeichert in:
| Veröffentlicht in: | World J Transplant |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4580930/ https://ncbi.nlm.nih.gov/pubmed/26421260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5500/wjt.v5.i3.81 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|